Experts discuss relevant and actionable strategies for practice improvement as well as timely clinic
How does inflammation in people living with HIV contribute to clustered comorbidities, and what stra
Learn how and why to improve the brain health of your patients. Credit available for this activity
Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-
Learn more about the latest guidelines and the importance of patient centricity when treating your p
What do ESC 2024 data mean for reducing cardiovascular risk in clinical practice with incretin-based
Did you know that artificial intelligence (AI) is shaping the future of oncology? Our expert faculty
Do you know how to identify individuals at risk for chikungunya virus-related disease who may benefi
Find out how to assess inflammation in people living with HIV, and how it drives early aging and com
Did you know that choosing between triplet and quadruplet regimens can make a significant difference
How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best
Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patien
Are you up to date on the most recent clinical guidelines and treatment options for myasthenia gravi
How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (
Learn from the experts about aligning treatments with patient expectations at first relapse of diffu
Learn from the experts about typical clinical scenarios, guidelines, and practical tips about lipopr
Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your
New subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your
Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire
What impact can weight loss have on the lives of your patients living with obesity? What treatment o
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developmen
PodQuest PodQuest Podcast Discovery Engine